ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 8–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Nov 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
December 2025
Nuclear Technology
November 2025
Fusion Science and Technology
Latest News
NRC cancels advanced reactor meeting due to government shutdown
The Nuclear Regulatory Commission has announced it is cancelling an upcoming advanced reactor stakeholder meeting, originally scheduled for November 19, due to the government shutdown and the limitations on staffing at the agency.
Thomas R. Jarboe
Fusion Science and Technology | Volume 36 | Number 1 | July 1999 | Pages 85-91
Technical Paper | doi.org/10.13182/FST99-A94
Articles are hosted by Taylor and Francis Online.
A steady inductive helicity injection (SIHI) method is described that has the following properties: (a) helicity is injected at a nearly constant rate; (b) neither magnetic energy nor helicity flow out of plasma at any time; (c) no open field lines penetrate the walls; (d) the equilibrium is produced in a close-fitting flux conserver; (e) a rotating magnetic structure is produced directly; and (f) in the frame of the rotating field, the current profile is nearly time independent and nearly optimum for the application discussed. SIHI can be applied to any toroidal plasma. Application of SIHI to a high-beta spheromak is described.